Skip to main content

Client News

XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development

3rd November 2021

MagForce AG Publishes Financial Results for H1/2021 and Operative Highlights

28th October 2021

Temedica Appoints Dr Christina Wagner as Chief Financial Officer

28th October 2021

Marinomed updates financial calendar and participates in upcoming industry and investor conferences

28th October 2021

InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum

27th October 2021

Adocia announces 2021 third quarter financial results and a financing of €7 million through the issuance of convertible bonds subscribed by European investors and ordinary shares subscribed by Gérard Soula, Adocia co-founder

27th October 2021

Marinomed partners with Perrigo to distribute virus-blocking Carragelose nasal spray in Scandinavia and France

27th October 2021

Secarna Pharmaceuticals and Denali Therapeutics expand strategic partnership for the discovery and development of novel ASO therapeutics in the field of CNS diseases

26th October 2021

Andera Partners supports Exciva in a Series A to fight Alzheimer’s disease

26th October 2021

EsoCap announces first patient enrolled in Phase II eosinophilic esophagitis trial

26th October 2021